Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Clinical trial NCT01749384 · COMPLETED
Trial details
- NCT number
- NCT01749384
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-06
- Primary completion
- 2016-05-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.